On January 26, Qualtrics International Inc. (XM) stock rebounded in the after-hours to gain a good 11.84%. The reason for this hike was the impressive Q4 and full-year 2021 financial results that the company posted on Wednesday.
During the regular trading session, the stock remained in the red with a loss of 1.22% at $24.25. Following the announcement, XM stock saw an upsurge in the after-hours. Hence, the stock reached $27.12 at an after-hours volume of 235.68K shares on Wednesday.
Currently, the company has a market capitalization of $14.01 billion with 147.31 million shares outstanding.
XM’s Fourth Quarter Financials
In the fourth quarter of 2021, XM generated total revenue of $316.0 million, against $213.6 million in Q4 of 2020. Thus, marking year over year growth of 48%.
Moreover, the company incurred a non-GAAP net loss of $39.4 million, against $8.1 million in the year-ago quarter. Resultantly, the non-GAAP net loss per share was $0.07 and $0.02 in Q4 of 2021 and 2020, respectively.
On December 31, 2021, the company had cash and cash equivalents of $1,041.5 million.
2021 Financial Highlights
For the full year of 2021, XM reported total revenue of $1,075.7 million, against $763.5 million for the previous year. Therefore, showing year-over-year growth of 41%.
Furthermore, the company suffered from a non-GAAP net loss of $6.0 million in fiscal 2021, against $46.0 million in the previous year. Subsequently, the non-GAAP net loss per basic and diluted share was $0.01 and $0.11 in the fiscal year 2021 and 2020, respectively.
Future Guidance
For Q1 2022, the company expects total revenue in the range of $324 million and $326 million with non-GAAP net income per share between $(0.02) and $0.00.
Additionally, the expected revenue for full-year 2022 is in the range of $1,402 and $1,406 million.
XM’s New Board Members
In addition, on Wednesday, the company also disclosed the appointment of Omar Johnson and Ritu Bhargava to its Board, effective immediately. With the addition of the new members, XM’s board of directors now consists of 11 directors in total.
Partnership with CLX Health
XM provides a software platform called Vaccination & Testing Manager. Through this solution, over 300 organizations (currently) manage Covid-19-related issues of their employees including vaccination documents and proof of exemption, etc.
On December 16, the company announced its partnership with a cloud-based solutions developer, CLX Health. According to the partnership, Qulatrics’ Vaccination & Testing Manager will be integrated with CLX’s TrustAssure platform. This will result in the verification of the documents uploaded on XM’s platform.
